Clinical Trial Update: Evaluation of Brain Atrophy in CIS Patients on Avonex

View source ↗

Summary

A completed clinical trial evaluated brain atrophy in patients with clinically isolated syndrome who were treated with Avonex (interferon beta-1a) for multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: University at Buffalo | Conditions: Multiple Sclerosis | Status: COMPLETED